{"id":"https://openalex.org/W2037048232","doi":"https://doi.org/10.1159/000079252","title":"Treatment of Ataxia in Cortical Cerebellar Atrophy with the GABAergic Drug Gabapentin","display_name":"Treatment of Ataxia in Cortical Cerebellar Atrophy with the GABAergic Drug Gabapentin","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2037048232","doi":"https://doi.org/10.1159/000079252","mag":"2037048232","pmid":"https://pubmed.ncbi.nlm.nih.gov/15218338"},"language":"en","primary_location":{"id":"doi:10.1159/000079252","doi":"https://doi.org/10.1159/000079252","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000079252","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087349137","display_name":"Jos\u00e9 Gazulla","orcid":"https://orcid.org/0000-0003-3061-6538","observed_orcids":["https://orcid.org/0000-0003-3061-6538"]},"institutions":[{"id":"https://openalex.org/I4210157026","display_name":"Hospital General San Jorge","ror":"https://ror.org/05e08c338","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210157026"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Gazulla","raw_affiliation_strings":["Section of Neurology, Hospital San Jorge, Huesca, Spain. josegazulla@wanadoo.es","Section of Neurology, Hospital San Jorge, Huesca,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Neurology, Hospital San Jorge, Huesca, Spain. josegazulla@wanadoo.es","institution_ids":["https://openalex.org/I4210157026"]},{"raw_affiliation_string":"Section of Neurology, Hospital San Jorge, Huesca,","institution_ids":["https://openalex.org/I4210157026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066563834","display_name":"Jose Maria Errea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 M. Errea","raw_affiliation_strings":["Unit of Neurology, Hospital Comarcal de Barbastro, Barbastro, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Neurology, Hospital Comarcal de Barbastro, Barbastro, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061252047","display_name":"Isabel Benavente\u2010Fern\u00e1ndez","orcid":"https://orcid.org/0000-0001-9276-1912","observed_orcids":["https://orcid.org/0000-0001-9276-1912"]},"institutions":[{"id":"https://openalex.org/I4210157026","display_name":"Hospital General San Jorge","ror":"https://ror.org/05e08c338","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210157026"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Isabel Benavente","raw_affiliation_strings":["Service of Neurophysiology, Hospital San Jorge, Huesca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of Neurophysiology, Hospital San Jorge, Huesca, Spain","institution_ids":["https://openalex.org/I4210157026"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068282000","display_name":"Carlos J. Tordesillas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157026","display_name":"Hospital General San Jorge","ror":"https://ror.org/05e08c338","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210157026"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos J. Tordesillas","raw_affiliation_strings":["Section of Neurology, Hospital San Jorge, Huesca,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Neurology, Hospital San Jorge, Huesca,","institution_ids":["https://openalex.org/I4210157026"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6514,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.5801643,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"52","issue":"1","first_page":"7","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.5249000191688538,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.5249000191688538,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.10159999877214432,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.05829999968409538,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ataxia","display_name":"ataxia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":1.0},{"id":"https://openalex.org/keywords/gabaergic-drugs","display_name":"GABAergic drugs","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cerebellar-signs","display_name":"cerebellar signs","score":0.9100000262260437},{"id":"https://openalex.org/keywords/gaba-deficiency","display_name":"GABA deficiency","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.9554518461227417},{"id":"https://openalex.org/C2780906641","wikidata":"https://www.wikidata.org/wiki/Q213373","display_name":"Ataxia","level":2,"score":0.7172331809997559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7004299163818359},{"id":"https://openalex.org/C2780148635","wikidata":"https://www.wikidata.org/wiki/Q154709","display_name":"Cerebellar ataxia","level":3,"score":0.6086465120315552},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.6068127155303955},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5181649923324585},{"id":"https://openalex.org/C2779652256","wikidata":"https://www.wikidata.org/wiki/Q130983","display_name":"Cerebellum","level":2,"score":0.5090115070343018},{"id":"https://openalex.org/C2781172350","wikidata":"https://www.wikidata.org/wiki/Q194520","display_name":"Atrophy","level":2,"score":0.4639351963996887},{"id":"https://openalex.org/C2992333117","wikidata":"https://www.wikidata.org/wiki/Q130983","display_name":"Cerebellar cortex","level":3,"score":0.4600079357624054},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.383438378572464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.279730886220932},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.16554632782936096},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.06444981694221497},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001284","descriptor_name":"Atrophy","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002524","descriptor_name":"Cerebellar Ataxia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002524","descriptor_name":"Cerebellar Ataxia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002525","descriptor_name":"Cerebellar Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002525","descriptor_name":"Cerebellar Cortex","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D013995","descriptor_name":"Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000079252","doi":"https://doi.org/10.1159/000079252","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000079252","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},{"id":"pmid:15218338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15218338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W50439370","https://openalex.org/W101894866","https://openalex.org/W1969510085","https://openalex.org/W2002501554","https://openalex.org/W2002871377","https://openalex.org/W2005763384","https://openalex.org/W2014316748","https://openalex.org/W2018919386","https://openalex.org/W2024188181","https://openalex.org/W2024330871","https://openalex.org/W2043288745","https://openalex.org/W2045890664","https://openalex.org/W2049422058","https://openalex.org/W2054722589","https://openalex.org/W2059592315","https://openalex.org/W2072705316","https://openalex.org/W2080447270","https://openalex.org/W2088991526","https://openalex.org/W2089519178","https://openalex.org/W2092094911","https://openalex.org/W2113209913","https://openalex.org/W2116471965","https://openalex.org/W2160456107","https://openalex.org/W2161973499","https://openalex.org/W2172635594","https://openalex.org/W2249279090","https://openalex.org/W2288818640","https://openalex.org/W2406515036","https://openalex.org/W2416951819","https://openalex.org/W2462538464","https://openalex.org/W2463514215","https://openalex.org/W2469730231","https://openalex.org/W3086885239","https://openalex.org/W3122228201"],"related_works":["https://openalex.org/W1982836067","https://openalex.org/W2086006952","https://openalex.org/W5441501","https://openalex.org/W2543707640","https://openalex.org/W2244807236","https://openalex.org/W6962705943","https://openalex.org/W4254309307","https://openalex.org/W2148494243","https://openalex.org/W3194497413","https://openalex.org/W1014706684"],"abstract_inverted_index":{"The":[0],"aim":[1],"of":[2,10,18,37,47,50,78,85,94,97,103,106,134,141,150,168,170,178],"this":[3,107],"work":[4],"was":[5,52,66,89,124],"to":[6,68,114,131],"investigate":[7],"the":[8,11,16,19,70,79,86,101,115,136,151,166,171],"efficacy":[9],"GABAergic":[12,156],"drug":[13,108,152],"gabapentin":[14,33,51,98],"in":[15,34,40,139,165],"treatment":[17,167],"cerebellar":[20,25,71,137,172],"signs":[21,72,138],"caused":[22],"by":[23],"cortical":[24],"atrophy":[26],"(CCA).":[27],"Ten":[28],"patients":[29],"with":[30,175],"CCA":[31],"received":[32],"single":[35,92,144],"doses":[36,93,145],"400":[38,95],"mg":[39,49,96,105],"an":[41,162],"open-label":[42],"study;":[43],"thereafter,":[44],"daily":[45],"administration":[46,77,102,149],"900-1,600":[48,104],"continued":[53,148],"during":[54,109,153],"at":[55,73,118],"least":[56],"4":[57,110,154],"weeks.":[58,155],"An":[59,120],"ataxia":[60,87],"scale":[61],"based":[62],"on":[63],"clinical":[64,122],"findings":[65],"used":[67],"evaluate":[69],"baseline":[74],"and":[75,99,146],"after":[76,91,100,143,147],"drug.":[80],"A":[81],"statistically":[82],"significant":[83],"improvement":[84],"scores":[88],"found":[90],"weeks,":[111],"as":[112],"compared":[113],"results":[116],"obtained":[117],"baseline.":[119],"important":[121,163],"amelioration":[123],"also":[125],"evident.":[126],"Gabapentin":[127],"has":[128],"been":[129],"demonstrated":[130],"be":[132],"capable":[133],"improving":[135],"cases":[140],"CCA,":[142],"enhancement":[157],"or":[158],"supplementation":[159],"could":[160],"play":[161],"role":[164],"diseases":[169],"cortex":[173],"associated":[174],"a":[176],"deficit":[177],"GABA.":[179]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}